[EN] COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS<br/>[FR] COMPOSÉS ET MÉTHODES POUR LE TRAITEMENT D'INFECTIONS BACTÉRIENNES
申请人:CIDARA THERAPEUTICS INC
公开号:WO2018006063A1
公开(公告)日:2018-01-04
Compositions and methods for the treatment of bacterial infections include compounds containing dimers of cyclic heptapeptides conjugated to one or more monosaccharide or oligosaccharide moieties. In particular, compounds can be used in the treatment of bacterial infections caused by Gram-negative bacteria.
Conotoxin analogues and methods for synthesis of intramolecular dicarba bridge-containing peptides
申请人:Robinson Andrea
公开号:US20070197429A1
公开(公告)日:2007-08-23
According to the present invention, there is provided a range of new conotoxin derivatives and methods for synthesizing these analogues and other intramolecular dicarba bridge-containing peptides, including dicarba-disulfide bridge-containing peptides.
Controlled Synthesis of (<i>S</i>,<i>S</i>)-2,7-Diaminosuberic Acid: A Method for Regioselective Construction of Dicarba Analogues of Multicystine-Containing Peptides
作者:Jomana Elaridi、Jim Patel、W. Roy Jackson、Andrea J. Robinson
DOI:10.1021/jo0606913
日期:2006.9.1
described. A sequence of ruthenium-catalyzedcrossmetathesis and rhodium-catalyzed hydrogenation of nonproteinaceous allylglycine derivatives has been developed to achieve high-yielding and unambiguous formation of diaminosuberic acid derivatives. Allylglycine derivatives readily undergo ruthenium-catalyzedmetathesis and hydrogenation to yield diaminosuberic acid derivatives in near quantitative yield
Regioselective formation of interlocked dicarba bridges in naturally occurring cyclic peptide toxins using olefin metathesis
作者:Andrea J. Robinson、Bianca J. van Lierop、Rebecca D. Garland、Euneace Teoh、Jomana Elaridi、Jayamini P. Illesinghe、W. Roy Jackson
DOI:10.1039/b909056h
日期:——
Bis-dicarba analogues of native dicystine-containing α-conotoxin Rg1A, an analgesic peptide isolated from cone snail venom, were constructed on resin using a regioselective metathesis–hydrogenation strategy.